Medtronic, Inc. (NYSE:MDT)

health care

Medical Device Maker’s IPO a Modest Success

Some initial public offerings (IPOs) are considered a huge success if the stock appreciates more than about 20% on its IPO date. To some, though, that's an unsuccessful launch from ...
Read Full Story »
NYSE-flag

Oppenheimer’s Stocks to Buy That Yield More Than the S&P 500

With volatility edging ever higher, investors have to look for at least a synthetic hedge to help them should there be a sizable correction. One of the best is solid ...
Read Full Story »
uncertainty market evolution

UBS Top Dividend Stocks to Buy as Quality Growth at a Reasonable Price

For some time we have kept a close eye on the UBS Quality Growth at a Reasonable Price list (Q-GARP) of stocks to buy. The firm focuses on names that ...
Read Full Story »
difidends

Deutsche Bank’s Eight True Dividend Growth Stocks to Buy Now

The rising volatility in the stock market has become somewhat similar to the yellow light on a traffic light. No reason necessarily to stop, depending on where you are, but ...
Read Full Story »
difidends

UBS Dividend Ruler Stocks to Buy for 2014 and Beyond

Equity investors are enjoying very nice gains in 2013. So far the S&P 500 is up 26.6%, the best performance since 1998. But the story is very different when UBS ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Lululemon, Priceline, Sprint, Tesla, Twitter and More

Earnings season is now winding down and stocks keep challenging new all-time highs. Now investors and traders alike are starting to decide how to best position their assets for 2014. ...
Read Full Story »
145922793

Top Oppenheimer Health Care Stocks to Buy for 2014

Health care has been a top sector for investors this year. The research team at Oppenheimer continues to believe that health care remains well positioned to deliver further market-topping returns ...
Read Full Story »
NYSE-flag

The Ten Most Important Earnings This Week

This week will be a busy one as far as earnings, but this is also marks the beginning of the end for corporate earnings. We also still have some DJIA ...
Read Full Story »
Boeing 787_10

UBS Adds Boeing and Others to Quality Growth List

What is Q-GARP? Quality growth at a reasonable price. The UBS Q-GARP list is constructed using an initial quantitative screen of stocks based on: 1) quality metrics— -- high and stable ...
Read Full Story »
Coca-Cola logo

UBS Adds New Top Stocks to Buy on Its Quality Growth at a Reasonable Price List

The UBS quality growth at a reasonable price recommendation list (Q-GARP) is very timely for investors concerned that the stock market may be overbought and ripe for a correction. The ...
Read Full Story »
131772836

UBS Dividend Ruler Stocks to Buy for the Rest of 2013: Intel, Medtronic and Others

Corporate America continues to increase cash payouts to shareholders at a high, shareholder-friendly rate. S&P 500 dividends per share growth accelerated to 15.5% in the second quarter. That was well ...
Read Full Story »
Money, US, $100 bills

UBS Dividend Ruler Stocks Combine Solid Yield and Growth Prospects

Over the past five weeks, the 10-year Treasury bond yield has increased by over one-half of one percent from 1.66% to 2.17%. The overall equity market has rallied 3.8% during ...
Read Full Story »
Digital Piracy

FDA Warns Medical Device Makers, Hospitals and Facilities to Protect Against Hackers, Malware, Cyberattacks

A new communication has been issued by the U.S. Food & Drug Administration (FDA) for medical device manufacturers. This may sound like it is out of a science fiction movie, ...
Read Full Story »
Wall St Bull statue

Top Analyst Upgrades and Stocks to Buy: Chesapeake, Citigroup, Monster and More

Investors and traders are always looking for new research ideas that will lead to higher income or more profits. 24/7 Wall St. reviews many fresh research calls each morning to find ...
Read Full Story »
Bull and Bear

Argus Makes Model Portfolio Changes (NUE, HCP, MDT, AMGN, HUM, ADI, JNPR, ELX, IPG)

Argus offers what is truly considered to be independent investment research. This gives the firm the lack of any or most of the traditional conflicts of interest that can be the ...
Read Full Story »